Revelation Biosciences Inc (REVB) — Capital Reinvestment Ratio
Revelation Biosciences Inc (REVB) has a Capital Reinvestment Ratio of 0.04x as of December 2018, meaning it reinvests 0% of its operating cash flow ($8.43 Million) in capital expenditures ($349.00K). Check tangible equity quality of Revelation Biosciences Inc to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Revelation Biosciences Inc Capital Reinvestment Ratio (2015–2019)
This chart tracks Revelation Biosciences Inc's Capital Reinvestment Ratio across 5 annual periods. For the full cash flow conversion analysis, see REVB cash flow metrics.
Annual Capital Reinvestment Ratio for Revelation Biosciences Inc (2015–2019)
Year-by-year Capital Reinvestment Ratio for Revelation Biosciences Inc from 2015 to 2019. See REVB free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.01x | $41.09 Million | $526.00K | ▼ -51.6% |
| 2018 | 0.03x | $32.58 Million | $861.00K | ▼ -20.3% |
| 2017 | 0.03x | $24.25 Million | $804.00K | ▼ -33.9% |
| 2016 | 0.05x | $11.60 Million | $582.00K | ▲ +0.0% |
| 2015 | 0.05x | $11.60 Million | $582.00K | — |